Details of the Drug

General Information of Drug (ID: DMM89G7)

• Drug Name: ASP4345

Indication

Disease Entry	ICD 11	Status	REF
Cognitive impairment	6D71	Phase 2	[1]

• Cross-matching ID:
  PubChem CID: 85470885
  TTD ID: D01ERE

References

• [1] ClinicalTrials.gov (NCT03557931) A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication. U.S. National Institutes of Health.